WHO records highest-ever number of new HIV cases in its European Region

STOCKHOLM (Reuters) – The World Health Organization (WHO) said on Thursday that in 2014 it had recorded the highest number of new HIV cases in its European Region, which also includes Central Asia, since the start of reporting in the 1980s.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bcf367c/sc/28/l/0L0Sreuters0N0Carticle0C20A150C110C260Cus0Ehealth0Ehiv0Ewho0EidUSKBN0ATF1OM20A1511260DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

U.S. court rejects Linden Care’s request for temporary restraining order

(Reuters) – A U.S. District Court on Wednesday denied specialty pharmacy Linden Care LLC’s request for a temporary restraining order (TRO) against Express Scripts Holding Co for dropping it from its network earlier this month.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bca934c/sc/7/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Elindencare0Elawsuit0EidUSKBN0ATE2VK20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Wheelchair users more likely to die in car crashes

(Reuters Health) – Wheelchair users may be more likely to die in collisions with cars than other pedestrians, an analysis of U.S. crash data suggests.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bca3ac1/sc/28/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Ehealth0Ewheelchairs0Etraffic0Esafety0EidUSKBN0ATE2R320A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Amgen files for U.S. approval of biosimilar to Humira

(Reuters) – Amgen Inc on Wednesday said it filed with U.S. health regulators seeking approval to sell its first biosimilar drug, which would be a less expensive alternative to AbbVie’s Humira, the world’s top-selling prescription medicine.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bca393f/sc/19/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Eamgen0Ebiosimilars0EidUSKBN0ATE2QS20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

For women with diabetes, air pollution has higher heart risks

(Reuters Health) – Particle pollution like soot is a known health hazard and linked to the risk of heart disease and stroke, but women with diabetes are even more vulnerable than most people, according to a new U.S. study.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bca37b5/sc/14/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Ehealth0Ediabetes0Eair0Epollution0EidUSKBN0ATE2QA20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Second language linked to better brain function after stroke

(Reuters Health) – People who speak two languages are twice as likely as those who only speak one to regain normal cognitive function after a stroke, according to a new study.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bca1ea1/sc/14/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Ehealth0Estroke0Elanguage0Ecognitive0EidUSKBN0ATE2NL20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Dermatology drug prices in U.S. soared in recent years

(Reuters Health) – The price of many drugs prescribed by U.S. dermatologists has skyrocketed over the past six years, far exceeding increases in overall health care costs and stretching patients’ budgets in an era of high insurance deductibles, according to a new study from Florida.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bc9c45d/sc/19/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Ehealth0Edrug0Eprices0Edermatology0EidUSKBN0ATE2JI20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Red meat linked to increased stroke risk

(Reuters Health) – Red meat – but not other types of protein – is linked to an increased stroke risk, and the odds go up the more meat people eat, a recent study suggests.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bc9bed4/sc/14/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Ehealth0Emeat0Estroke0Erisk0EidUSKBN0ATE2IA20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

EU approves Roche’s Cotellic in combo therapy against skin cancer

ZURICH (Reuters) – The European Union gave its green light to Roche’s Cotellic for use in combination with the drug Zelboraf against advanced melanoma, the company said on Wednesday.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bc8507d/sc/19/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Eroche0Ecotellic0EidUSKBN0ATE1XI20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

Pfizer’s Lyrica shows no relief from post-traumatic nerve pain

(Reuters) – Pfizer Inc said its blockbuster pain drug, Lyrica, had failed to show benefit in patients suffering from a type of post-traumatic nerve pain, in a late-stage study.

Source: http://reuters.us.feedsportal.com/c/35217/f/654207/s/4bc7bb3d/sc/26/l/0L0Sreuters0N0Carticle0C20A150C110C250Cus0Epfizer0Estudy0EidUSKBN0ATE1MN20A1511250DfeedType0FRSS0GfeedName0FhealthNews/story01.htm